Atelerix

Developer of small-molecule therapeutics for opioid addiction

placeCharlottesville, Virginia, United States calendar_todayFounded 2020 groups5 employees language atelerixlifesciences.com

Registered entities

Social engagement

Social engagement: 95 social following, 1 post in the last 12 months — top quartile of its industry.

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%

Recent activity

10 Jul 2025
Product launch
Atelerix Life Sciences website
Coming soon